QGEN
QIAGEN Delivers Strong Performance in 2024 Q4: Exceeds Sales and Adjusted Earnings Targets
QIAGEN, a leading global provider of Sample to Insight solutions to transform biological materials into meaningful molecular insights, has delivered a strong performance in the fourth quarter of 2024. According to the company's recent conference call transcript, QIAGEN exceeded its targets for sales and adjusted earnings, solidifying its